Skip to main content
Research project

Precision Targeting of human iNKT Cells for Cancer Immunotherapy

Project overview

Exploiting iNKT cells for cancer treatment

Staff

Lead researchers

Professor Salah Mansour PhD

Professor
Research interests
  • Unconventional T cells and lipid antigen recognition in human disease
  • CD1-restricted T cell immunity, including group 1 CD1, iNKT and γδ T cells
  • Molecular and structural mechanisms of CD1-mediated antigen presentation
Connect with Salah

Professor Ali Roghanian PhD, FHEA

Professor
Research interests
  • Cancer immunotherapy
  • Monoclonal antibodies
  • Cellular therapies (e.g., CAR T and iNKT cells)
Connect with Ali

Dr Diana Garay Baquero

Research Fellow
Connect with Diana

Research outputs